Home/Filings/8-K/0001104659-26-002743
8-K//Current report

CVRx, Inc. 8-K

Accession 0001104659-26-002743

$CVRXCIK 0001235912operating

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 8:57 AM ET

Size

514.1 KB

Accession

0001104659-26-002743

Research Summary

AI-generated summary of this filing

Updated

CVRx, Inc. Enters $50M At-the-Market Sales Agreement

What Happened

  • On January 12, 2026, CVRx, Inc. announced it entered into an Open Market Sale Agreement with Jefferies LLC under which the company may offer and sell up to $50.0 million of its common stock in an at-the-market offering. Sales would be made under the company’s effective Form S-3 registration (File No. 333-291309) and a prospectus supplement dated January 12, 2026. The company intends to use net proceeds for working capital and general corporate purposes.

Key Details

  • Amount: up to $50.0 million of common stock may be offered and sold from time to time.
  • Agent and fees: Jefferies LLC is the sales agent and may receive up to 3.0% of gross proceeds as commission; CVRx also agreed to reimburse certain agent expenses.
  • Timing & mechanics: Shares may be sold as an “at-the-market” offering under Rule 415; the company is not obligated to sell any shares and the agreement may be terminated as provided in the contract.
  • Registration: Sales will be made pursuant to CVRx’s Form S-3 that was declared effective December 15, 2025 (prospectus supplement dated January 12, 2026).

Why It Matters

  • This agreement gives CVRx a flexible way to raise capital quickly by selling shares into the open market as needed, which can help fund operations or general corporate needs without a single large offering.
  • For investors, such programs can lead to dilution if the company sells shares; the filing confirms the potential source of future share issuance but does not commit CVRx to sell any shares.
  • The cost of the program includes a commission (up to 3.0%) and other agent expenses, which will reduce net proceeds when sales are made.